Communicable diseases in northwest Syria in the context of protracted armed conflict and earthquakes.


Journal

The Lancet. Infectious diseases
ISSN: 1474-4457
Titre abrégé: Lancet Infect Dis
Pays: United States
ID NLM: 101130150

Informations de publication

Date de publication:
11 2023
Historique:
received: 27 02 2023
revised: 21 03 2023
accepted: 22 03 2023
medline: 30 10 2023
pubmed: 8 7 2023
entrez: 7 7 2023
Statut: ppublish

Résumé

The earthquakes in Türkiye and Syria in February, 2023, have caused further devastation in northwest Syria-an area already affected by protracted armed conflict, mass forced displacement, and inadequate health and humanitarian provision. The earthquake damaged infrastructure supporting water, sanitation, and hygiene, and health-care facilities. The disruptions to epidemiological surveillance and ongoing disease control measures resulting from the earthquake will accelerate and expand ongoing and new outbreaks of many communicable diseases including measles, cholera, tuberculosis, and leishmaniasis. Investing in existing early warning and response network activities in the area is essential. Antimicrobial resistance, which had already been an increasing concern in Syria before the earthquake, will also be exacerbated given the high number of traumatic injuries and breakdown of antimicrobial stewardship, and the collapse of infection prevention and control measures. Tackling communicable diseases in this setting requires multisectoral collaboration at the human-animal-environment nexus given the effect of the earthquakes on all these sectors. Without this collaboration, communicable disease outbreaks will further strain the already overburdened health system and cause further harm to the population.

Identifiants

pubmed: 37419130
pii: S1473-3099(23)00201-3
doi: 10.1016/S1473-3099(23)00201-3
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e477-e481

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests We declare no competing interests.

Auteurs

Maia C Tarnas (MC)

University of California, Irvine, CA, USA.

Naser Almhawish (N)

Syria Public Health Network, London, UK.

Nabil Karah (N)

Department of Molecular Biology. Umea University, Umea, Sweden.

Richard Sullivan (R)

Institute of Cancer Policy and the Centre for Conflict & Health Research, King's College London, London, UK.

Aula Abbara (A)

Syria Public Health Network, London, UK; Department of Infectious Diseases, St Marys Hospital, Imperial College London, London, UK. Electronic address: a.abbara15@ic.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH